With multiple coronavirus vaccine candidates under development, the global race for a COVID-19 vaccine is well underway, revealing numerous crucial and pressing questions. Will vaccines be effective and safe? How soon might we see success? How willing will the public be to accept a new vaccine? Which groups will gain access first — which groups should get access first? And where do treatments fit in? Reuters’ Michele Gershberg and Professor Barry Bloom addressed these issues and took viewer questions in this Facebook Live event.
This event was presented jointly by The Forum at the Harvard T.H. Chan School of Public Health and Reuters on September 15, 2020.
